Results 191 to 200 of about 3,311,310 (295)

Hydrogel Films with Impact Resistance by Sacrificial Micelle-Assisted-Alignment. [PDF]

Adv Sci (Weinh)
Zhang J, Shi X, Zhao Z, Wang M, Deng H, Du Y.   +5 more
europepmc   +1 more source

Investigation of Impact Resistance of High-Strength Portland Cement Concrete Containing Steel Fibers. [PDF]

Materials (Basel), 2022
Mohtasham Moein M, Saradar A, Rahmati K, Hatami Shirkouh A, Sadrinejad I, Aramali V, Karakouzian M.   +6 more
europepmc   +1 more source

Estimating the impact of antimicrobial resistance [PDF]

The Lancet Global Health, 2018
Nobuaki, Matsunaga, Kayoko, Hayakawa
openaire   +2 more sources

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Optimal sandwich panel's core design for an enhanced impact resistance. [PDF]

Heliyon
Charkaoui A, Hassan NM, Bahroun Z.
europepmc   +1 more source

Study on Bone-like Microstructure Design of Carbon Nanofibers/Polyurethane Composites with Excellent Impact Resistance. [PDF]

Nanomaterials (Basel), 2022
Gao J, Yang H, Xiang Z, Zhang B, Ouyang X, Qi F, Zhao N.   +6 more
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Impact Resistance of Aluminum Foam Composites with Filler and Coating Materials. [PDF]

Polymers (Basel)
Wu Y, Guo Y, Yi S, Lv Z, Fan Z.
europepmc   +1 more source

Experimental Investigation of Cracking and Impact Resistance of Polymer- and Fiber-Enhanced Concrete for Ultra-Thin Whitetopping. [PDF]

Polymers (Basel), 2022
Chen L, Zheng S, Li X, Cheng Z, Wang X.
europepmc   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source